The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...

As the chill of winter approaches, most of us are well-versed in the annual warnings about the flu and, more recently, ...

"Respiratory viral infections (RVIs) are associated with elevated cardiovascular risk; however, less is known about cardiac ...

The study authors say flu or RSV may increase the risk of S pneumoniae infection by damaging the bronchi and lung epithelium, ...

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...

The World Health Organization (WHO) has published its first ever position paper on immunization against respiratory syncytial ...

The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income ...

Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...

Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

Kellee was diagnosed with Respiratory Syncytial Virus (RSV), a virus many assume is only serious for young children. For ...